(Q38097487)

28 August 2017

Impact and management of Campylobacter in human medicine--US perspective (English)

1 reference

28 August 2017

1 reference

Mark S Pasternack

1

1 reference

28 August 2017

1 December 2002

1 reference

International Journal of Infectious Diseases

28 August 2017

1 reference

28 August 2017

6 Suppl 3

1 reference

28 August 2017

3S37-42; discussion 3S42-3, 3S53-8

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

28 August 2017

1 reference

7 January 2021

Susceptibility of Campylobacter isolates to the bactericidal activity of human serum

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Campylobacter bacteraemia in England and Wales, 1981-91

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Campylobacter jejuni and the expanding spectrum of related infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV).

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Bacterial enteric infections in persons infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Campylobacter sepsis in human immunodeficiency virus-infected children. The Madrid HIV Pediatric Infection Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Rifabutin prophylaxis against Mycobacterium avium complex infections in HIV-infected patients: impact on the incidence of campylobacteriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Use of an immunoglobulin M containing preparation for treatment of two hypogammaglobulinemic patients with persistent Campylobacter jejuni infection

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

An unusual case of refractory Campylobacter jejuni infection in a patient with X-linked agammaglobulinemia: successful combined therapy with maternal plasma and ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Epidemiologic and clinical features of Campylobacter jejuni infections

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Campylobacter jejuni Infections: update on emerging issues and trends

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Chronic sequelae of foodborne disease

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Rheumatic manifestations of Campylobacter jejuni and C. fetus infections in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Campylobacter jejuni infection as a cause of the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Clinical and epidemiologic features of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

New concepts of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Empirical antimicrobial therapy for traveler's diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Health advice and immunizations for travelers.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

Practice guidelines for the management of infectious diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2802%2990182-7

7 January 2021

10.1016/S1201-9712(02)90182-7

Identifiers

DOI

0 references

PubMed ID

23570172

1 reference

PubMed ID

23570172